Assyro AI

Orange Book product · Brand (NDA)

BRONCHITOL

MANNITOL

Brand (NDA)NDA 202049RX PHARMAXIS EUROPE

At a glance

Oct 30, 2020

Approved

Brand (NDA)

Application

Not listed

TE code

None

Listed patents

Key dates

  1. Approval

    FDA approval date of this drug product.

    Oct 30, 2020

    5 yr 9 mo ago

  2. Today

  3. Exclusivity ends · ODE-327

    Orphan-drug exclusivity (7 years)

    Oct 30, 2027

    in 1 yr 5 mo

Pharmaceutical detail

Active ingredient

MANNITOL

Strength

40MG

Dosage form

POWDER

Route

INHALATION

TE code

Not listed

Application

NDA 202049

Product number

001

Marketing status

RX

Reference listed drug (RLD)

Yes

Reference standard (RS)

Yes

Active-ingredient family

View full family

This is a reference-listed drug (RLD) — the basis for generic (ANDA) applications. Other products sharing this ingredient are listed below.

Marketing exclusivity (1)

  • ODE-327Orphan-drug exclusivity (7 years)

    Oct 30, 2027

    in 1 yr 5 mo

Listed patents

No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Agent CTA Background

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.